Literature DB >> 25183788

Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging.

Nathan S White1, Carrie McDonald, Carrie R McDonald2, Niky Farid3, Josh Kuperman3, David Karow3, Natalie M Schenker-Ahmed3, Hauke Bartsch3, Rebecca Rakow-Penner3, Dominic Holland3, Ahmed Shabaik4, Atle Bjørnerud5, Tuva Hope6, Jona Hattangadi-Gluth7, Michael Liss8, J Kellogg Parsons8, Clark C Chen9, Steve Raman10, Daniel Margolis10, Robert E Reiter11, Leonard Marks11, Santosh Kesari12, Arno J Mundt7, Christopher J Kane, Christopher J Kaine8, Bob S Carter9, William G Bradley3, Anders M Dale13.   

Abstract

Diffusion-weighted imaging (DWI) has been at the forefront of cancer imaging since the early 2000s. Before its application in clinical oncology, this powerful technique had already achieved widespread recognition due to its utility in the diagnosis of cerebral infarction. Following this initial success, the ability of DWI to detect inherent tissue contrast began to be exploited in the field of oncology. Although the initial oncologic applications for tumor detection and characterization, assessing treatment response, and predicting survival were primarily in the field of neurooncology, the scope of DWI has since broadened to include oncologic imaging of the prostate gland, breast, and liver. Despite its growing success and application, misconceptions about the underlying physical basis of the DWI signal exist among researchers and clinicians alike. In this review, we provide a detailed explanation of the biophysical basis of diffusion contrast, emphasizing the difference between hindered and restricted diffusion, and elucidating how diffusion parameters in tissue are derived from the measurements via the diffusion model. We describe one advanced DWI modeling technique, called restriction spectrum imaging (RSI). This technique offers a more direct in vivo measure of tumor cells, due to its ability to distinguish separable pools of water within tissue based on their intrinsic diffusion characteristics. Using RSI as an example, we then highlight the ability of advanced DWI techniques to address key clinical challenges in neurooncology, including improved tumor conspicuity, distinguishing actual response to therapy from pseudoresponse, and delineation of white matter tracts in regions of peritumoral edema. We also discuss how RSI, combined with new methods for correction of spatial distortions inherent in diffusion MRI scans, may enable more precise spatial targeting of lesions, with implications for radiation oncology and surgical planning. See all articles in this Cancer Research section, "Physics in Cancer Research." ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 25183788      PMCID: PMC4155409          DOI: 10.1158/0008-5472.CAN-13-3534

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  76 in total

1.  Multi-component apparent diffusion coefficients in human brain.

Authors:  R V Mulkern; H Gudbjartsson; C F Westin; H P Zengingonul; W Gartner; C R Guttmann; R L Robertson; W Kyriakos; R Schwartz; D Holtzman; F A Jolesz; S E Maier
Journal:  NMR Biomed       Date:  1999-02       Impact factor: 4.044

2.  Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model.

Authors:  Kevin M Bennett; Kathleen M Schmainda; Raoqiong Tong Bennett; Daniel B Rowe; Hanbing Lu; James S Hyde
Journal:  Magn Reson Med       Date:  2003-10       Impact factor: 4.668

3.  Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

4.  Combined use of tractography-integrated functional neuronavigation and direct fiber stimulation.

Authors:  Kyousuke Kamada; Tomoki Todo; Yoshitaka Masutani; Shigeki Aoki; Kenji Ino; Tetsuya Takano; Takaaki Kirino; Nobutaka Kawahara; Akio Morita
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

5.  Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.

Authors:  W B Pope; A Lai; R Mehta; H J Kim; J Qiao; J R Young; X Xue; J Goldin; M S Brown; P L Nghiemphu; A Tran; T F Cloughesy
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-17       Impact factor: 3.825

6.  Diffusion parameters of the extracellular space in human gliomas.

Authors:  Lýdia Vargová; Ales Homola; Josef Zámecník; Michal Tichý; Vladimír Benes; Eva Syková
Journal:  Glia       Date:  2003-04-01       Impact factor: 7.452

Review 7.  How good is MRI at detecting and characterising cancer within the prostate?

Authors:  Alexander P S Kirkham; Mark Emberton; Clare Allen
Journal:  Eur Urol       Date:  2006-06-30       Impact factor: 20.096

8.  Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging.

Authors:  C-H Toh; M Castillo; A M-C Wong; K-C Wei; H-F Wong; S-H Ng; Y-L Wan
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-07       Impact factor: 3.825

9.  Motor and language DTI Fiber Tracking combined with intraoperative subcortical mapping for surgical removal of gliomas.

Authors:  Lorenzo Bello; Anna Gambini; Antonella Castellano; Giorgio Carrabba; Francesco Acerbi; Enrica Fava; Carlo Giussani; Marcello Cadioli; Valeria Blasi; Alessandra Casarotti; Costanza Papagno; Arun K Gupta; Sergio Gaini; Giuseppe Scotti; Andrea Falini
Journal:  Neuroimage       Date:  2007-08-29       Impact factor: 6.556

10.  Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM.

Authors:  Nikdokht Farid; Daniela B Almeida-Freitas; Nathan S White; Carrie R McDonald; Karra A Muller; Scott R Vandenberg; Santosh Kesari; Anders M Dale
Journal:  Front Oncol       Date:  2013-09-30       Impact factor: 6.244

View more
  57 in total

1.  Restriction spectrum imaging improves MRI-based prostate cancer detection.

Authors:  Kevin C McCammack; Natalie M Schenker-Ahmed; Nathan S White; Shaun R Best; Robert M Marks; Jared Heimbigner; Christopher J Kane; J Kellogg Parsons; Joshua M Kuperman; Hauke Bartsch; Rahul S Desikan; Rebecca A Rakow-Penner; Michael A Liss; Daniel J A Margolis; Steven S Raman; Ahmed Shabaik; Anders M Dale; David S Karow
Journal:  Abdom Radiol (NY)       Date:  2016-05

2.  Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.

Authors:  Carrie R McDonald; Rachel L Delfanti; Anitha P Krishnan; Kelly M Leyden; Jona A Hattangadi-Gluth; Tyler M Seibert; Roshan Karunamuni; Pia Elbe; Joshua M Kuperman; Hauke Bartsch; David E Piccioni; Nathan S White; Anders M Dale; Nikdokht Farid
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

Review 3.  Translating preclinical MRI methods to clinical oncology.

Authors:  David A Hormuth; Anna G Sorace; John Virostko; Richard G Abramson; Zaver M Bhujwalla; Pedro Enriquez-Navas; Robert Gillies; John D Hazle; Ralph P Mason; C Chad Quarles; Jared A Weis; Jennifer G Whisenant; Junzhong Xu; Thomas E Yankeelov
Journal:  J Magn Reson Imaging       Date:  2019-03-29       Impact factor: 4.813

4.  Restriction spectrum imaging reveals decreased neurite density in patients with temporal lobe epilepsy.

Authors:  Richard Q Loi; Kelly M Leyden; Akshara Balachandra; Vedang Uttarwar; Donald J Hagler; Brianna M Paul; Anders M Dale; Nathan S White; Carrie R McDonald
Journal:  Epilepsia       Date:  2016-10-13       Impact factor: 5.864

5.  In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.

Authors:  K C McCammack; C J Kane; J K Parsons; N S White; N M Schenker-Ahmed; J M Kuperman; H Bartsch; R S Desikan; R A Rakow-Penner; D Adams; M A Liss; R F Mattrey; W G Bradley; D J A Margolis; S S Raman; A Shabaik; A M Dale; D S Karow
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-01-12       Impact factor: 5.554

6.  Use of intravoxel incoherent motion diffusion-weighted MR imaging for assessment of treatment response to invasive fungal infection in the lung.

Authors:  Chenggong Yan; Jun Xu; Wei Xiong; Qi Wei; Ru Feng; Yuankui Wu; Qifa Liu; Caixia Li; Queenie Chan; Yikai Xu
Journal:  Eur Radiol       Date:  2016-05-14       Impact factor: 5.315

7.  Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702).

Authors:  Habib Rahbar; Zheng Zhang; Thomas L Chenevert; Justin Romanoff; Averi E Kitsch; Lucy G Hanna; Sara M Harvey; Linda Moy; Wendy B DeMartini; Basak Dogan; Wei T Yang; Lilian C Wang; Bonnie N Joe; Karen Y Oh; Colleen H Neal; Elizabeth S McDonald; Mitchell D Schnall; Constance D Lehman; Christopher E Comstock; Savannah C Partridge
Journal:  Clin Cancer Res       Date:  2019-01-15       Impact factor: 12.531

Review 8.  Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.

Authors:  Ryan L Brunsing; Natalie M Schenker-Ahmed; Nathan S White; J Kellogg Parsons; Christopher Kane; Joshua Kuperman; Hauke Bartsch; Andrew Karim Kader; Rebecca Rakow-Penner; Tyler M Seibert; Daniel Margolis; Steven S Raman; Carrie R McDonald; Nikdokht Farid; Santosh Kesari; Donna Hansel; Ahmed Shabaik; Anders M Dale; David S Karow
Journal:  J Magn Reson Imaging       Date:  2016-08-16       Impact factor: 4.813

Review 9.  New prostate MRI techniques and sequences.

Authors:  Aritrick Chatterjee; Carla Harmath; Aytekin Oto
Journal:  Abdom Radiol (NY)       Date:  2020-12

10.  Neurite orientation dispersion and density imaging can detect presymptomatic axonal degeneration in the spinal cord of ALS mice.

Authors:  R G Gatto; S M Mustafi; M Y Amin; T H Mareci; Yu-Chien Wu; R L Magin
Journal:  Funct Neurol       Date:  2018 Jul/Sept
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.